Total Funding
46
44
Total FundingPost-IPO Equity raised
Growth Score
-2 pts
Heat Score
14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
136309
Viveve develops non-surgical treatment for women who have experienced vaginal looseness and loss of physical sensation.
- Scott Durbin: CEO & Director
- Scott Durbin: Chief Executive Officer
Viveve Medical
About the Company
Viveve is a women's sexual health company that develops non-surgical treatment for women's sexual health. It focuses on developing a Viveve procedure, a non-surgical treatment for women who have experienced vaginal looseness and loss of physical sensation that is common to women after vaginal childbirth. The company’s Viveve System is a
radiofrequency device that uses low levels of energy to restore collagen fibers overstretched and damaged during vaginal childbirth.
Viveve, Inc. was formerly known as TiVaMed, Inc. and changed its name to Viveve, Inc. in November 2009. The company was founded in 2005 and is based in Palo Alto, California.
